<s>[INST] Is there a cure for T1D? [/INST] Not yet, but thanks to decades of JDRF-funded research, we know what is necessary for finding cures for T1D:

Turn off the autoimmune attack that destroys the insulin-producing beta cells
Restore insulin production inside or replace them with cells from outside the body
To accomplish that, JDRF has three priority areas of research:

Global Universal Screening
There’s a simple blood test that can detect T1D autoantibodies, an established marker of risk of developing T1D—and ensuring more people have access to it can have a transformative effect on the landscape of T1D research and save lives at the same time.

Disease-Modifying Therapies
T1D is a progression. There are people whose own immune system has begun attacking the insulin producing beta cells, but they are not symptomatic yet. There are also people who have had T1D for decades and have lost nearly all insulin production. Disease-modifying therapies are aimed at helping everyone with T1D—regardless of where they are on the disease continuum.
In 2022, the first-ever disease-modifying therapy for individuals at risk of developing T1D was approved by the FDA. This was a watershed moment for the T1D community and puts us on the critical pathway to finding cures and, one day, preventing T1D entirely.

Cell Therapies
Thanks to recent advances, people with T1D could one day be freed from their blood-glucose monitors and insulin injections for years, or even decades. JDRF’s Cell Therapies Program invests in research and clinical trials to develop and deliver life-changing therapies that place healthy, insulin-producing beta or islet cells back into the bodies of people with T1D.
 Source: JDRF. Link: https://www.jdrf.org/t1d-resources/about/faq/. Field: Endocrine. Disease: Diabetes </s>